Press & Publications

Press release

Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics

Article

Accure Therapeutics presented at ECTRIMS four communications reporting the progress of ACT-01 neuroprotective therapy for Multiple Sclerosis

Press release

Accure Therapeutics enrols first patient in phase II clinical trial on acute optic neuritis with lead candidate ACT-01

Article

New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis